Skip to main content


Media Coverage

Low Risk General Wellness Devices - FDA Finalizes Guidance and Further Illuminates Its Policy of Enforcement Discretion

September-October 2016
Food and Drug Law Institute
In a bylined article, Litigation & Dispute Resolution partners Mark Mansour and Christopher Mikson and associate Emily Strunk (all Washington DC) discuss the recently finalized FDA guidance on its policy of enforcement discretion.

Related Information

  • Related People
    Christopher M. Mikson, MD
    T +1 202 263 3157
    Emily K. Strunk
    T +1 202 263 3404
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.